Zobrazeno 1 - 10
of 10
pro vyhledávání: '"de Morrée ES"'
Autor:
Mout L; Department of Medical Oncology Erasmus MC-Cancer Institute, Dr. Molewaterplein 40, 3015 GD, Rotterdam, The Netherlands.; Department of Urology Erasmus University MC, Dr. Molewaterplein 40, 3015 GD, Rotterdam, The Netherlands., Moll JM; Department of Urology Erasmus University MC, Dr. Molewaterplein 40, 3015 GD, Rotterdam, The Netherlands., Chen M; Division of Pharmaceutics College of Pharmacy, The Ohio State University, 217 Lloyd M. Parks Hall, 500 West 12th Avenue, Columbus, OH, 43210, USA., de Morrée ES; Department of Medical Oncology Erasmus MC-Cancer Institute, Dr. Molewaterplein 40, 3015 GD, Rotterdam, The Netherlands.; Department of Urology Erasmus University MC, Dr. Molewaterplein 40, 3015 GD, Rotterdam, The Netherlands., de Ridder CMA; Department of Urology Erasmus University MC, Dr. Molewaterplein 40, 3015 GD, Rotterdam, The Netherlands., Gibson A; Division of Pharmaceutics College of Pharmacy, The Ohio State University, 217 Lloyd M. Parks Hall, 500 West 12th Avenue, Columbus, OH, 43210, USA., Stuurman D; Department of Urology Erasmus University MC, Dr. Molewaterplein 40, 3015 GD, Rotterdam, The Netherlands., Aghai A; Department of Urology Erasmus University MC, Dr. Molewaterplein 40, 3015 GD, Rotterdam, The Netherlands., Erkens-Schulze S; Department of Urology Erasmus University MC, Dr. Molewaterplein 40, 3015 GD, Rotterdam, The Netherlands., Mathijssen RHJ; Department of Medical Oncology Erasmus MC-Cancer Institute, Dr. Molewaterplein 40, 3015 GD, Rotterdam, The Netherlands., Sparreboom A; Division of Pharmaceutics College of Pharmacy, The Ohio State University, 217 Lloyd M. Parks Hall, 500 West 12th Avenue, Columbus, OH, 43210, USA., de Wit R; Department of Medical Oncology Erasmus MC-Cancer Institute, Dr. Molewaterplein 40, 3015 GD, Rotterdam, The Netherlands., Lolkema MP; Department of Medical Oncology Erasmus MC-Cancer Institute, Dr. Molewaterplein 40, 3015 GD, Rotterdam, The Netherlands., van Weerden WM; Department of Urology Erasmus University MC, Dr. Molewaterplein 40, 3015 GD, Rotterdam, The Netherlands. w.vanweerden@erasmusmc.nl.
Publikováno v:
British journal of cancer [Br J Cancer] 2020 Dec; Vol. 123 (12), pp. 1715-1719. Date of Electronic Publication: 2020 Sep 29.
Autor:
de Morrée ES; Erasmus MC Cancer Institute, Department of Medical Oncology, Rotterdam, the Netherlands., Vogelzang NJ; US Oncology Research, Houston, Texas3Comprehensive Cancer Centers of Nevada, Las Vegas, Nevada., Petrylak DP; Yale Cancer Center, Division of Oncology, Department of Medicine, New Haven, Connecticut., Budnik N; NSHI Dorozhnaya Clinical Hospital of OAO Russian Railways, Rostov-on-Don, Russia., Wiechno PJ; Department of Uro-Oncology, Centrum Onkologii - Instytut im. Marii Sklodowskiej-Curie, Warsaw, Poland., Sternberg CN; San Camillo and Forlanini Hospitals, Department of Medical Oncology, Rome, Italy., Doner K; Texas Oncology, Austin., Bellmunt J; University Hospital del Mar-IMIM, Barcelona, Spain10Dana Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts., Burke JM; US Oncology Research, Houston, Texas11Rocky Mountain Cancer Centers, Aurora, Colorado., Ochoa de Olza M; Catalan Institute of Oncology, Department of Medical Oncology, Barcelona, Spain., Choudhury A; Department of Clinical Oncology, The Christie NHS Foundation Trust and Institute of Cancer Sciences, University of Manchester, Manchester, England., Gschwend JE; Department of Urology, Rechts der Isar Medical Center, Technische Universität München, München, Germany., Kopyltsov E; State Institution of Healthcare ' Regional Clinical Oncology Dispensary', Omsk, Russia., Flechon A; Centre Léon Bérard, Department of Medical Oncology, Lyon, France., van As N; Department of Clinical Oncology, Royal Marsden Hospital, London, England., Houede N; Medical Oncology Department, Groupe Hospitalier Universitaire Caremeau Place du Professeur Robert Debré, Nîmes, France., Barton D; Celgene Corporation, Summit, New Jersey., Fandi A; Celgene Corporation, Summit, New Jersey., Jungnelius U; Celgene Corporation, Summit, New Jersey., Li S; Celgene Corporation, Summit, New Jersey., Li JS; Celgene Corporation, Summit, New Jersey., de Wit R; Erasmus MC Cancer Institute, Department of Medical Oncology, Rotterdam, the Netherlands.
Publikováno v:
JAMA oncology [JAMA Oncol] 2017 Jan 01; Vol. 3 (1), pp. 68-75.
Autor:
de Morrée ES; Department of Urology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Wytemaweg 80, 3015 CN, Rotterdam, The Netherlands., Böttcher R; Department of Urology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Wytemaweg 80, 3015 CN, Rotterdam, The Netherlands.; Department of Bioinformatics, TUAS Wildau, Wildau, Germany., van Soest RJ; Department of Urology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Wytemaweg 80, 3015 CN, Rotterdam, The Netherlands., Aghai A; Department of Urology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Wytemaweg 80, 3015 CN, Rotterdam, The Netherlands., de Ridder CM; Department of Urology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Wytemaweg 80, 3015 CN, Rotterdam, The Netherlands., Gibson AA; Division of Pharmaceutics and Pharmaceutical Chemistry, The Ohio State University, Columbus, OH, USA., Mathijssen RH; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Wytemaweg 80, 3015 CN, Rotterdam, The Netherlands., Burger H; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Wytemaweg 80, 3015 CN, Rotterdam, The Netherlands., Wiemer EA; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Wytemaweg 80, 3015 CN, Rotterdam, The Netherlands., Sparreboom A; Division of Pharmaceutics and Pharmaceutical Chemistry, The Ohio State University, Columbus, OH, USA., de Wit R; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Wytemaweg 80, 3015 CN, Rotterdam, The Netherlands., van Weerden WM; Department of Urology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Wytemaweg 80, 3015 CN, Rotterdam, The Netherlands.
Publikováno v:
British journal of cancer [Br J Cancer] 2016 Sep 06; Vol. 115 (6), pp. 674-81. Date of Electronic Publication: 2016 Aug 18.
Autor:
van Soest RJ; Department of Urology, Erasmus University Medical Center, Erasmus MC Cancer Institute, Rotterdam, The Netherlands. Electronic address: r.vansoest@erasmusmc.nl., de Morrée ES; Department of Urology, Erasmus University Medical Center, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Kweldam CF; Department of Pathology, Erasmus University Medical Center, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Wiemer EA; Department of Medical Oncology, Erasmus University Medical Center, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Mathijssen RH; Department of Medical Oncology, Erasmus University Medical Center, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., de Wit R; Department of Medical Oncology, Erasmus University Medical Center, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., van Weerden WM; Department of Urology, Erasmus University Medical Center, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
Publikováno v:
European urology [Eur Urol] 2016 Mar; Vol. 69 (3), pp. e43-4. Date of Electronic Publication: 2015 Jul 30.
Autor:
van Soest RJ; Department of Urology, Erasmus University Medical Center and Cancer Institute, Rotterdam, The Netherlands. Electronic address: r.vansoest@erasmusmc.nl., Nieuweboer AJ; Department of Medical Oncology, Erasmus University Medical Center and Cancer Institute, Rotterdam, The Netherlands., de Morrée ES; Department of Urology, Erasmus University Medical Center and Cancer Institute, Rotterdam, The Netherlands., Chitu D; Department of Biostatistics, Erasmus University Medical Center and Cancer Institute, Rotterdam, The Netherlands., Bergman AM; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Goey SH; Department of Internal Medicine, Tweesteden Hospital, Tilburg, The Netherlands., Bos MM; Department of Internal Medicine, Reinier de Graaf Hospital, Delft, The Netherlands., van der Meer N; Department of Clinical Trial Center, Erasmus University Medical Center and Cancer Institute, Rotterdam, The Netherlands., Hamberg P; Department of Internal Medicine, St Franciscus Gasthuis and Prostate Cancer Center, Rotterdam, The Netherlands., de Wit R; Department of Medical Oncology, Erasmus University Medical Center and Cancer Institute, Rotterdam, The Netherlands., Mathijssen RH; Department of Medical Oncology, Erasmus University Medical Center and Cancer Institute, Rotterdam, The Netherlands.
Publikováno v:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2015 Nov; Vol. 51 (17), pp. 2562-9. Date of Electronic Publication: 2015 Aug 13.
Autor:
Nieuweboer AJ; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands. Electronic address: a.nieuweboer@erasmusmc.nl., de Morrée ES; Department of Urology, Erasmus University Medical Center, Rotterdam, The Netherlands., de Graan AJ; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Sparreboom A; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands; Department of Pharmaceutical Sciences, St Jude Children's Research Hospital, Memphis, TN, United States., de Wit R; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Mathijssen RH; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
Publikováno v:
Cancer treatment reviews [Cancer Treat Rev] 2015 Jul; Vol. 41 (7), pp. 605-13. Date of Electronic Publication: 2015 May 07.
Autor:
van Soest RJ; Department of Urology, Erasmus University Medical Center, Erasmus MC Cancer Institute, Rotterdam, The Netherlands. Electronic address: r.vansoest@erasmusmc.nl., de Morrée ES; Department of Urology, Erasmus University Medical Center, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Kweldam CF; Department of Pathology, Erasmus University Medical Center, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., de Ridder CMA; Department of Urology, Erasmus University Medical Center, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Wiemer EAC; Department of Medical Oncology, Erasmus University Medical Center, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Mathijssen RHJ; Department of Medical Oncology, Erasmus University Medical Center, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., de Wit R; Department of Medical Oncology, Erasmus University Medical Center, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., van Weerden WM; Department of Urology, Erasmus University Medical Center, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
Publikováno v:
European urology [Eur Urol] 2015 Jun; Vol. 67 (6), pp. 981-985. Date of Electronic Publication: 2014 Dec 04.
Autor:
Wissing MD; Department of Clinical Oncology, Leiden University Medical Center, Leiden, the Netherlands. Department of Urology, Leiden University Medical Center, Leiden, the Netherlands. Contributed equally to this work., De Morrée ES; Department of Urology, Erasmus MC-Cancer Institute, Rotterdam, the Netherlands. Contributed equally to this work., Dezentjé VO; Department of Clinical Oncology, Leiden University Medical Center, Leiden, the Netherlands., Buijs JT; Department of Urology, Leiden University Medical Center, Leiden, the Netherlands., De Krijger RR; Department of Pathology, Reinier de Graaf Gasthuis, Delft, the Netherlands., Smit VT; Department of Pathology, Leiden University Medical Center, Leiden, the Netherlands., Van Weerden WM; Department of Urology, Erasmus MC-Cancer Institute, Rotterdam, the Netherlands., Gelderblom H; Department of Clinical Oncology, Leiden University Medical Center, Leiden, the Netherlands., van der Pluijm G; Department of Urology, Leiden University Medical Center, Leiden, the Netherlands.
Publikováno v:
Oncotarget [Oncotarget] 2014 Sep 15; Vol. 5 (17), pp. 7357-67.
Autor:
van Soest RJ; Department of Urology, Erasmus University Medical Center, Rotterdam, The Netherlands. Electronic address: r.vansoest@erasmusmc.nl., de Morrée ES; Department of Urology, Erasmus University Medical Center, Rotterdam, The Netherlands., Shen L; Sanofi, Malvern, PA, USA., Tannock IF; Department of Medical Oncology and Hematology, Princess Margaret Hospital, Toronto, ON, Canada., Eisenberger MA; Department of Oncology, The Johns Hopkins Medical Institutions, Baltimore, MD, USA., de Wit R; Department of Medical Oncology, Erasmus University Medical Center and Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
Publikováno v:
European urology [Eur Urol] 2014 Aug; Vol. 66 (2), pp. 330-6. Date of Electronic Publication: 2013 Aug 11.
Autor:
van Soest RJ; Department of Urology, Erasmus University Medical Center, Erasmus MC Cancer Institute, Rotterdam, The Netherlands. Electronic address: r.vansoest@erasmusmc.nl., van Royen ME, de Morrée ES, Moll JM, Teubel W, Wiemer EA, Mathijssen RH, de Wit R, van Weerden WM
Publikováno v:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2013 Dec; Vol. 49 (18), pp. 3821-30. Date of Electronic Publication: 2013 Oct 24.